Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eiger Biopharmaceuticals (EIGR – Research Report), Sanofi (SNYNF – Research Report) and Processa Pharmaceuticals (PCSA – Research Report).
Eiger Biopharmaceuticals (EIGR)
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Eiger Biopharmaceuticals, with a price target of $28.00. The company’s shares closed last Thursday at $4.65.
According to TipRanks.com, Higgins is a 4-star analyst with an average return of
Currently, the analyst consensus on Eiger Biopharmaceuticals is a Strong Buy with an average price target of $35.00, implying a 627.7% upside from current levels. In a report issued on October 27, Robert W. Baird also maintained a Buy rating on the stock with a $29.00 price target.
See today’s best-performing stocks on TipRanks >>
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Sanofi today and set a price target of EUR85.00. The company’s shares closed last Thursday at $86.75.
According to TipRanks.com, Papadakis is a 4-star analyst with an average return of
Sanofi has an analyst consensus of Moderate Buy, with a price target consensus of $100.94, a 16.7% upside from current levels. In a report issued on October 28, Kepler Capital also downgraded the stock to Hold with a EUR89.00 price target.
Processa Pharmaceuticals (PCSA)
In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Processa Pharmaceuticals, with a price target of $9.00. The company’s shares closed last Thursday at $2.16, close to its 52-week low of $1.50.
According to TipRanks.com, Rahman has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on Processa Pharmaceuticals is a Moderate Buy with an average price target of $8.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EIGR:
- Hershey Delivers a Sweet Q3; Raises Outlook
- Analysts Offer Insights on Technology Companies: CareCloud, Inc. (MTBC) and Rolls-Royce Holdings (OtherRYCEF)
- Needham Sticks to Their Buy Rating for Paylocity (PCTY)
- Needham Keeps Their Buy Rating on Thryv Holdings (THRY)
- Maxim Group Sticks to Its Buy Rating for Whitestone REIT (WSR)